Your browser doesn't support javascript.
loading
Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures.
Mulder, Bart A; Al-Jazairi, Meelad I H; Magni, Federico T; Groenveld, Hessel F; Tieleman, Robert G; Wiesfeld, Ans C P; Tan, Yong E S; Van Gelder, Isabelle C; Rienstra, Michiel; Blaauw, Yuri.
Afiliação
  • Mulder BA; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands b.a.mulder@umcg.nl.
  • Al-Jazairi MIH; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Magni FT; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Groenveld HF; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Tieleman RG; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Wiesfeld ACP; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Tan YES; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Van Gelder IC; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Rienstra M; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Blaauw Y; Thorax Center, Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
Open Heart ; 8(2)2021 12.
Article em En | MEDLINE | ID: mdl-34949648
ABSTRACT

INTRODUCTION:

Pulmonary vein isolation (PVI) is an important treatment for atrial fibrillation (AF). However, many patients need more than one procedure to maintain long-term sinus rhythm. Even after two PVIs some may suffer from AF recurrences. We aimed to identify characteristics of patients who fail after two PVI procedures. METHODS AND

RESULTS:

We included 557 consecutive patients undergoing a first PVI procedure with a second-generation 28 mm cryoballoon. Follow-up procedures were performed using radiofrequency ablation targeting reconnected PVs only. Recurrent AF was defined as any episode of AF lasting >30 s on ECG or 24 hour Holter monitoring performed at 3, 6 and 12 months post procedure. Mean age was 59.1±10.2 years, 383 (68.8%) were male, 448 (80.4%) had paroxysmal AF and the most common underlying condition was hypertension (36.6%). A total of 140/557 (25.1%) patients underwent redo procedure with PVI only. Of these patients 45 (32.4%) had recurrence of AF. These patients were comparable regarding age and sex to those in sinus rhythm after one or two procedures. Multivariate logistic regression showed that non-paroxysmal AF (OR 1.08 (95% CI 1.01 to 1.15), estimated glomerular filtration rate (OR 0.96, 95% CI 0.94 to 0.99), bundle branch block (OR 4.17, 95% CI 1.38 to 12.58), heart failure (OR 4.17, 95% CI 1.38 to 12.58) and Left Atrium Volume Index (OR 1.04, 95% CI 1.01 to 1.08) were associated with AF recurrence after two PVIs. The area under the curve for the identified risk factors was 0.74.

CONCLUSIONS:

Using a PVI-only approach, recurrence of AF after two AF ablation procedures is associated with more advanced underlying disease and persistent types of AF.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Veias Pulmonares / Fibrilação Atrial / Eletrocardiografia Ambulatorial / Ablação por Cateter Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Veias Pulmonares / Fibrilação Atrial / Eletrocardiografia Ambulatorial / Ablação por Cateter Idioma: En Ano de publicação: 2021 Tipo de documento: Article